This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishibashi, T. Articles by Furuhata, H. Search for Related Content PubMed PubMed Citation Articles by Ishibashi, T. Articles by Furuhata, H. Pubmed/NCBI databases Substance via MeSH Related Collections Thrombolysis

(Stroke. 2002;33:1399.)
© 2002 American Heart Association, Inc.

Original Contributions

Can Transcranial Ultrasonication Increase Recanalization Flow With Tissue Plasminogen Activator?

Toshihiro Ishibashi, MD; Masahiko Akiyama, MD; Hisashi Onoue, MD; Toshiaki Abe, MD Hiroshi Furuhata, MD, PhD

From the Department of Neurosurgery (T.I., M.A., H.O., T.A.) and Medical Engineering Laboratory (H.F.), Jikei University School of Medicine, Tokyo, Japan.

Correspondence to Toshihiro Ishibashi, MD (E-mail isb{at}fd6.so-net.ne.jp), Department of Neurosurgery, or Hiroshi Furuhata, MD, PhD (E-mail furuhata@jikei.ac.jp), Department of Medical Engineering Laboratory, Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.

Background and Purpose— In thrombolytic therapy for acute ischemic stroke, it is essential to obtain rapid thrombolysis before ischemic neuronal injury occurs. To develop a new technique of thrombolysis for acute ischemic stroke, the effect of transcranially applied ultrasound (TUS) on thrombolysis was examined.

Methods— An occlusion model of rabbit femoral artery was produced with thrombin after establishment of stenotic flow and endothelial damage. After stable occlusion was confirmed, monteplase (mtPA) was administered intravenously, and ultrasound (490 kHz, 0.13 W/cm²) was applied through a piece of temporal bone (TUS group; n=9). The control group received mtPA alone (tissue plasminogen activator [tPA] group; n=12). To verify the efficacy of TUS, femoral artery flow was measured during the procedure.

Results— The recanalization ratio was 16.7% (2 of 12) in the tPA group and 66.7% (6 of 9) in the TUS group. The recanalization ratio in the TUS group was higher than that in the tPA group (P=0.03). Patency flow ratio, which was defined as recanalization flow divided by baseline flow, of the TUS group (44.6±13.9%) was significantly greater than that of the tPA group (9.9±6.8%) at 60 minutes (P=0.025). Patency flow ratio became higher in the TUS group than in the tPA group between 20 and 30 minutes from the start of thrombolysis.

Conclusions— Low-frequency and low-intensity TUS enhanced thrombolysis by mtPA in a rabbit femoral artery occlusion model. This technique should be clinically useful for thrombolysis in acute ischemic stroke.

Key Words: thrombolytic therapy • tissue plasminogen activator • ultrasonography, transcranial • rabbits

This article has been cited by other articles:

				T. Saguchi, H. Onoue, M. Urashima, T. Ishibashi, T. Abe, and H. Furuhata Effective and Safe Conditions of Low-Frequency Transcranial Ultrasonic Thrombolysis for Acute Ischemic Stroke: Neurologic and Histologic Evaluation in a Rat Middle Cerebral Artery Stroke Model Stroke, March 1, 2008; 39(3): 1007 - 1011. [Abstract] [Full Text] [PDF]

				T. Wilhelm-Schwenkmezger, P. Pittermann, K. Zajonz, O. Kempski, M. Dieterich, and M. Nedelmann Therapeutic Application of 20-kHz Transcranial Ultrasound in an Embolic Middle Cerebral Artery Occlusion Model in Rats: Safety Concerns Stroke, March 1, 2007; 38(3): 1031 - 1035. [Abstract] [Full Text] [PDF]

				F. Schneider, T. Gerriets, M. Walberer, C. Mueller, R. Rolke, B. M. Eicke, J. Bohl, O. Kempski, M. Kaps, G. Bachmann, et al. Brain Edema and Intracerebral Necrosis Caused by Transcranial Low-Frequency 20-kHz Ultrasound: A Safety Study in Rats Stroke, May 1, 2006; 37(5): 1301 - 1306. [Abstract] [Full Text] [PDF]

				M. Daffertshofer, A. Gass, P. Ringleb, M. Sitzer, U. Sliwka, T. Els, O. Sedlaczek, W. J. Koroshetz, and M. G. Hennerici Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia: Increased Risk of Hemorrhage With Combined Ultrasound and Tissue Plasminogen Activator: Results of a Phase II Clinical Trial Stroke, July 1, 2005; 36(7): 1441 - 1446. [Abstract] [Full Text] [PDF]

				S. Pfaffenberger, B. Devcic-Kuhar, C. Kollmann, S. P. Kastl, C. Kaun, W. S. Speidl, T. W. Weiss, S. Demyanets, R. Ullrich, H. Sochor, et al. Can a Commercial Diagnostic Ultrasound Device Accelerate Thrombolysis?: An In Vitro Skull Model Stroke, January 1, 2005; 36(1): 124 - 128. [Abstract] [Full Text] [PDF]

				S. Hahnel, P. D. Schellinger, A. Gutschalk, K. Geletneky, M. Hartmann, M. Knauth, and K. Sartor Local Intra-arterial Fibrinolysis of Thromboemboli Occurring During Neuroendovascular Procedures With Recombinant Tissue Plasminogen Activator Stroke, July 1, 2003; 34(7): 1723 - 1728. [Abstract] [Full Text] [PDF]